| Lindsay Boettger, MA, LPCC, ADC | |
|
1400 Madison Ave, Suite 628, Mankato, MN 56001-5473 | |
| (507) 779-7366 | |
| (507) 779-7367 |
| Full Name | Lindsay Boettger |
|---|---|
| Gender | Female |
| Speciality | Counselor - Professional |
| Location | 1400 Madison Ave, Mankato, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043618564 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YP2500X | Counselor - Professional | CC00904 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lindsay Boettger, MA, LPCC, ADC 1400 Madison Ave, Suite 628, Mankato, MN 56001-5473 Ph: (507) 779-7366 | Lindsay Boettger, MA, LPCC, ADC 1400 Madison Ave, Suite 628, Mankato, MN 56001-5473 Ph: (507) 779-7366 |
News Archive
Genervon Biopharmaceuticals LLC today announced that it has successfully completed its Phase 2a clinical trial for amyotrophic lateral sclerosis ("ALS") disease modification. A full analysis of the trial's results is expected to be completed in the third quarter of 2014, but preliminary data suggests that Genervon's novel, proprietary, multi-target biological drug candidate, GM604, shows significant promise for treating ALS.
The spinach-eating cartoon character Popeye has much to teach us, new research from the Swedish medical university Karolinska Institutet shows. The muscles' cellular power plants - the mitochondria - are boosted by nitrate, a substance found in abundance in vegetables such as lettuce, spinach and beetroot.
Patients have ‘very limited' knowledge of their rights as laid out in the NHS Constitution, the Patients Association says.
Medivation, Inc. and Astellas Pharma Inc. today announced treatment of the first patient in a second Phase 3 clinical trial of the investigational drug MDV3100, which expands the Phase 3 development of the novel, triple-acting oral androgen receptor antagonist into an earlier-stage patient population. Known as PREVAIL, the trial will evaluate MDV3100 in men with advanced prostate cancer who have not yet received chemotherapy. Initiation of the PREVAIL trial triggers a milestone payment to Medivation under its collaboration agreement with Astellas.
› Verified 4 days ago
Tiffany Faye Vanderziel, MA, LPCC Counselor Medicare: Medicare Enrolled Practice Location: 201 N Broad St Ste 200, Mankato, MN 56001 Phone: 507-335-1500 Fax: 507-225-1501 | |
Trevor Allen Schabert, MS, LPCC Counselor Medicare: Medicare Enrolled Practice Location: 201 N Broad St Ste 200, Mankato, MN 56001 Phone: 507-225-1500 Fax: 507-225-1501 | |
Stephanie Sanetel-siatsis, MS, LPCC, NCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 510 Sibley St, Mankato, MN 56001 Phone: 507-484-2400 | |
Katelin Michelle Farmer, MSW, LGSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 501 N Riverfront Dr, Mankato, MN 56001 Phone: 727-366-8056 | |
Aaron Geringer, LPCC Counselor Medicare: Not Enrolled in Medicare Practice Location: 530 N Riverfront Dr Ste 140, Mankato, MN 56001 Phone: 612-460-5881 | |
Wren Leith, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1650 Madison Ave Ste 102, Mankato, MN 56001 Phone: 507-345-7012 |